person

Linda T.

Country
Sweden
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 9 partner sites.

Specializations

Breast Cancer Therapeutics

The investigator concentrates on innovative approaches for advanced and early‑stage breast cancer, emphasizing hormone‑receptor status and HER2 expression.

  • Targeted endocrine strategies for ER‑positive disease
  • HER2‑directed antibody‑drug conjugates in metastatic settings
  • Neoadjuvant regimens for triple‑negative tumors
  • Combination therapies for HER2‑low disease

These efforts aim to refine response‑driven treatment pathways across the disease spectrum.

Prostate Cancer & Hormone‑Driven Malignancies

Focused on metastatic castration‑sensitive and castration‑resistant prostate cancer, the investigator evaluates molecularly selected agents and radiographic biomarkers.

  • PSMA‑PET guided salvage radiotherapy after surgery
  • PARP inhibitor combinations in HRR‑mutated disease
  • Androgen receptor pathway inhibition with novel hormonal agents
  • Adjuvant strategies for high‑risk post‑prostatectomy recurrence

Research integrates precision genomics with systemic and local treatment modalities.

Cardiovascular, Metabolic and Renal Disorders

The investigator addresses heart failure phenotypes, atrial fibrillation, and metabolic syndromes, linking renal function to cardiovascular outcomes.

  • SGLT2 inhibitor combinations for HFpEF and kidney impairment
  • Anticoagulant alternatives for stroke prevention in atrial fibrillation
  • Fluid‑management protocols in critical care patients with fluid overload
  • Metabolic modulation of abdominal aortic aneurysm growth

These projects target integrated cardiometabolic risk reduction.

Gastrointestinal Oncology and Inflammatory Bowel Disease

Research spans colorectal and anal canal malignancies as well as immune‑mediated intestinal disorders.

  • Biomarker‑driven neoadjuvant therapy for stage II‑III colorectal cancer
  • Immunotherapy in microsatellite‑instable (MSI‑H) tumors
  • Combination regimens for locally advanced anal squamous carcinoma
  • Pediatric efficacy of biologics in moderate‑to‑severe Crohn’s disease

The work integrates molecular profiling with targeted and immune‑based treatments.

Infectious Diseases and Immunology

Efforts include viral respiratory infections, HIV management, and allergic airway disease, with a focus on immune modulation.

  • Monoclonal antibody therapy for severe viral lung infection
  • Long‑acting regimens for HIV‑1 suppression
  • Allergen immunotherapy for birch pollen‑induced rhinoconjunctivitis
  • Preventive vaccination strategies against emerging monkeypox

These studies advance therapeutic options across acute and chronic infectious contexts.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.